Skip to main content

Hologic

Product
Tests
Description of Project

This investment will enable Hologic, Inc. to expand production capacity for COVID-19 tests in their supplier’s facilities, increasing their production capacity to 13 million COVID-19 tests per month by January 2022.

Unique Impact

 This investment will enable Hologic to improve the supply to laboratories across the country in addition to scaling up employment in Hologic supplier facilities and support the demand for COVID-19 testing in the United States.

Base Award Amount
$7,506,725.76
Category
Testing Capacity and Raw Materials